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Buerger’s disease is a nonatherosclerotic, inflam-
matory, segmental vascular occlusive disease of
unknown etiology, which involves medium and small
arteries and veins of the limbs, only rarely affecting
visceral or cerebral vessels. The disease was described
and established in the English literature by Leo
Buerger in 19081 as a clinicopathologic entity distinct
from atherosclerosis. Today, Buerger’s disease is
accepted as a definite vascular disease with a typical
clinical picture, natural history, and histopathology.2-5
The diagnosis of Buerger’s disease, however, remains
controversial because of conflicting criteria used by
many authors.3-6 Pathologic diagnosis is considered
of secondary importance.2,4,7 Arteries from patients
with Buerger’s disease have not been analyzed with
inflammatory infiltrating cell-specific monoclonal
antibodies to discover whether cells of the immune
system play a role in its pathogenesis.
Findings from nine patients, in whom Buerger’s
disease was diagnosed according to our criteria,4,8,9 are
summarized. The histologic and immunohistochemi-
cal features of Buerger’s disease were described with
monoclonal antibodies directed against surface anti-
gens of T lymphocytes, B lymphocytes, macrophages,
dendritic cells, and activated cells to identify the phe-
notypes of infiltrating cells and determine the distribu-
tion of various cell components in the arterial lesions.
MATERIALS AND METHODS
Case selection. Thirty-three specimens from
nine patients, in whom Buerger’s disease was diag-
nosed on the basis of our clinical and angiographic
criteria (Table I) between 1980 and 1995 at Nagoya
University Hospital, were studied. These materials
were retrieved from the surgical pathology files of
Nagoya University Hospital. Seven patients were
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Purpose: The diagnosis of Buerger’s disease has depended on clinical symptoms and
angiographic findings, whereas pathologic findings are considered to be of secondary
importance. Arteries from patients with Buerger’s tissue were analyzed histologically,
including immunophenotyping of the infiltrating cells, to elucidate the nature of
Buerger’s disease as a vasculitis.
Methods: Thirty-three specimens from nine patients, in whom Buerger’s disease was diag-
nosed on the basis of our clinical and angiographic criteria between 1980 and 1995 at
Nagoya University Hospital, were studied. Immunohistochemical studies were per-
formed on paraffin-embedded tissue with a labeled streptoavidin-biotin method.
Results: The general architecture of vessel walls was well preserved regardless of the stage
of disease, and cell infiltration was observed mainly in the thrombus and the intima.
Among infiltrating cells, CD3+ T cells greatly outnumbered CD20+ B cells. CD68+
macrophages or S-100+ dendritic cells were detected, especially in the intima during
acute and subacute stages. All cases except one showed infiltration by the human leuko-
cyte antigen-D region (HLA-DR) antigen-bearing macrophages and dendritic cells in
the intima. Immunoglobulins G, A, and M (IgG, IgA, IgM) and complement factors 3d
and 4c (C3d, C4c) were deposited along the internal elastic lamina.
Conclusion: Buerger’s disease is strictly an endarteritis that is introduced by T-cell medi-
ated cellular immunity and by B-cell mediated humoral immunity associated with acti-
vation of macrophages or dendritic cells in the intima. (J Vasc Surg 1999;29:451-8.)
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men, and two were women; the mean age of the
patients at surgery was 43.4 years.
Light microscopic examination. All tissue was
obtained from amputated limbs or other surgical
specimens with informed consent from all patients.
Paraffin-embedded tissue sections were stained with
hematoxylin-eosin and elastica-van Gieson.
Immunohistochemistry. Immunohistochemical
studies were performed on paraffin-embedded tissue
by means of a labeled streptoavidin-biotin method.
The primary antibodies used in this study, their speci-
ficities, and working dilution are listed in Table II.
Endogenous peroxidase activity was blocked with
0.3% H2O2 in methanol for 30 minutes. For some
antibodies, antigen expression was enhanced by means
of pretreatment with either 0.5% trypsin digestion at
37°C for 30 minutes or heating in a microwave for 5
minutes twice in 0.1 mol/L citrate buffer at pH 6.0
(Table II). After incubation with primary antibodies
overnight at 4°C, slides were incubated with biotiny-
lated secondary antibodies (DAKO, A/S, Denmark)
for 60 minutes and streptoavidin-peroxidase complex
(Nichirei, Japan) for 60 minutes at room temperature.
Color development used 3,3 ¢ -diaminobenzidine as
chromogen with 0.005% hydrogen peroxide, followed
by counterstaining with Mayer’s hematoxylin.
Quantification of infiltrating cells on tissue
sections. Each sample was viewed at 200· magnifi-
cation high-power fields, and 20 randomly selected
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Fig 1. A, Typical acute lesion of the popliteal artery with thrombosis in Buerger’s disease.
(Original magnification, 40· ; hematoxylin-eosin stain.) Fresh thrombus (F) and organizing
thrombus (O) were seen in the lumen. There is a remarkable inflammatory cell infiltration in
the intima and the organizing thrombus. Microabscesses and a multinucleated giant cell (boxed
area) are observed in the organizing thrombus. M, Media. B, High-power view of boxed area
in Fig 1, A, showing microabscess and multinucleated giant cell (arrowhead; original magnifi-
cation, 400· ; hematoxylin-eosin stain). These phagocytic giant cells are positive for CD68 and
HLA-DR (not shown). C, The internal elastic lamina (arrowhead) is essentially intact in
Buerger’s disease (original magnification, 100· ; elastica-van Gieson stain).
Table I. Clinical criteria for diagnosis of Buerger’s
disease
1 Smoking history
2 Onset before the age of 50
3 Infrapopliteal arterial occlusive lesions
4 Either upper-limb involvement or phlebitis migrans
5 Absence of atherosclerotic risk factors other than smoking
By Shionoya’s criteria,4 the clinical diagnosis of Buerger’s disease
is made only when all five requirements are met.
fields were analyzed in each section. In each case, the
grades of positivity were as follows: –, negative in
each field; 1+, 1% to 10% of the infiltrating cells pos-
itive per field at original magnification (100· ); 2+,
11% to 20% positive; 3+, more than 20% positive.
Control samples. Arteries of three lower limbs
affected with obliterative arteriosclerosis were used
as controls.
RESULTS
Histologic findings. The nine cases examined
are subdivided into one case of acute stage, two
cases of subacute stage, and six cases of chronic
stage, according to histologic criteria.4,7,8 Case 1
showed a typical acute-stage lesion. The lumen was
occluded by fresh thrombus and intimal thickening
with remarkable infiltration of leukocytes, including
neutrophils (Fig 1A). Multinucleated giant cells
were seen (Fig 1B), but fibrinoid necrosis or granu-
lomatous lesions were not observed. Two cases (case
2 and 3) had the histologic features of the subacute
stage. These specimens had lumens occluded by
fresh and organized thrombus with partial recanal-
ization. Multinucleated giant cells were not found in
thrombi or vessel walls (Fig 2A). Six cases had
chronic-stage lesions. The occlusive thrombi were
organized and recanalized extensively, and mild cell
infiltration was seen in the intima, media, and adven-
titia (Fig 2B). The common features in all nine cases
were general architecture and elastic laminae that
remained essentially intact (Fig 1C) and cell infiltra-
tion that was observed predominantly in the throm-
bi and intima. No specimens revealed calcification
and atheromatous plaque in the vessel walls.
Immunohistochemical findings. Immunohis-
tochemical findings are summarized in Tables III
and IV. There were more infiltrating cells in acute
and subacute lesions than in chronic ones. Most of
the infiltrating cells were seen in the intima, where
CD3+ T cells, which recognize all T lymphocytes,
outnumbered CD20+ B cells, which define all B
lymphocytes, in ratios ranging from 2:1 to 5:1 in
acute lesions (Fig 3A). Particularly in the chronic
stage, CD20+ B cells were more scarce than CD3+ T
cells. Though the CD3+ T cells were seen mainly in
the intima, some were scattered in the media and
adventitia. In T lymphocyte subsets, CD8+ T cells,
which recognize the suppressor/inducer subset of T
lymphocytes, were observed as often as CD4+ T
cells, which define the helper/inducer subset of T
lymphocytes, in the acute stage (Fig 3B,C), unlike
their normal ratio in blood. In the chronic stage, the
number of CD8+ cells predominated slightly over
CD4+ T cells.
CD68+ cells, which define the macrophages,
were observed particularly in thrombi and intima
during the acute and subacute phases (Fig 4A). The
population of CD68+ cells was second in abundance,
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Fig 2. Photograph of subacute stage lesion (A) and chronic stage lesion (B). In the subacute
lesion, fresh thrombi and organized thrombi are seen. A remarkable cell infiltration is observed
in the thrombus and intima, however, it is scarce in the media (M). In the chronic lesion, the
lumen is occluded by organized thrombi with recanalized vessels. Even in the chronic lesion,
cell infiltration was observed. Note the internal elastic lamina is almost intact, regardless of the
stage. F, fresh thrombus; O, organizing thrombus.
after the number of CD3+ cells. S-100+ cells, which
recognize dendritic cells, were readily detected in the
intimal layer (Fig 4B), but very few were detected in
the media or adventitia in acute or subacute lesions.
Particularly, S-100+ dendritic cells in the thrombi and
intima showed well-developed processes. More than
95% of S-100+ cells showed the CD68 antigen simul-
taneously. Very few S-100+ dendritic cells were rec-
ognized in chronic stage lesions. CD57+ and CD56+
natural-killer cells were observed scarcely in the
thrombi and intima and media, however, not at all in
the adventitia.
In all stages, especially acute and subacute
lesions, HLA-DR+ macrophages and dendritic
cells were observed in the thrombi and intima (Fig
4). Giant cells in acute stage lesions expressed
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Table II. Antibodies and pretreatment used in this study
Antibody Specificity Clone Source Dilution Pretreatment
CD3 Pan T cell DAKO, Japan · 150 0.5% trypsin
CD4 T helper/inducer cell OPD4 DAKO, A/S, Denmark · 100
CD8 T suppressor/cytotoxic cell DK25 DAKO, A/S, Denmark · 100 Heating in a microwave
CD20 Pan B cell L-26 DAKO, Japan ¥ 200
CD68 Macrophage, monocyte PG-M1 DAKO, Japan · 100
CD68 Macrophage, monocyte KP-1 DAKO, Japan · 150 0.5% trypsin
CD57 NK cell Leu7 Becton-Dickinson · 200
CD34 Endothelial cell QBEND/10 Seikagaku Corp. · 80
S-100 Dendritic cell DAKO, Japan · 500
HLA-DR Activation antigen DK22 DAKO, Japan · 50
IgG Gamma chain DAKO, Japan · 2400 0.5% trypsin
IgA Alpha chain DAKO, Japan · 400 0.5% trypsin
IgM Mu chain DAKO, Japan · 2400 0.5% trypsin
C3d complement C3d DAKO, A/S, Denmark · 200 0.5% trypsin
C4c complement C4c DAKO, A/S, Denmark · 200 0.5% trypsin
Fig 3. Cell infiltration along the internal elastic lamina (arrowhead), showing immunohisto-
chemical staining for CD3 (A), CD8 (B), CD4 (C), and CD20 (D), respectively (brown cyto-
plasm; original magnification, 400· ). The upper part, above the internal elastic lamina, is the
media, and the lower part is the intima. Infiltrating cells are more obvious in the intimal layer
than in the media. CD3+ cells outnumbered CD20+ cells in acute-stage lesions (A, D). CD8+
T cells slightly predominate over CD4+ T cells (C, D).
HLA-DR and CD68 simultaneously, but never
expressed S-100 on the cell.
IgG, IgA, and IgM were found to be deposited
in a linear manner along the inner aspect of the
internal elastic lamina (Fig 5A). Complement fac-
tors, C3d and C4c, were found to be deposited in a
similar manner (Fig 5B).
The atherosclerotic control cases revealed
fibrous intimal proliferation and hyaline degenera-
tion and calcification in the media. The elastic lam-
ina was severely reduplicated or fragmented or dis-
rupted, in contrast with the intact elastic lamina in
Buerger’s disease. Leukocytic infiltration was
observed in all three layers, however, its population
was scarce (Fig 6). CD3+ cells were predominant,
and among T lymphocytes, CD4+ T cells outnum-
bered CD8+ T cells. None of the three cases showed
a linear distribution of IgG, IgA, IgM, C3c, and
C4d along the area of elastic lamina, again in con-
trast with Buerger’s disease. In the intima, HLA-
DR+ cells were observed much less often than in
Buerger’s disease.
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Fig 4. A, CD68+ cells are abundant in the intimal layer. B, HLA-DR+ cells are distributed in
the intimal layer, along the internal elastic lamina. C, S-100+ cells (arrowhead) are found in the
intimal layer in acute stage lesion. More than 95% of these S-100+ cells show the CD68 anti-
gen simultaneously. Most of the CD68+ cells and S-100+ cells express HLA-DR antigen. 
(A, CD68; B, HLA-DR; C, S-100; original magnification, 400· .)
Fig 5. A, Deposition of IgG (arrow) and, B, complement factor 4 (C4c, arrowhead) along
the internal elastic lamina, respectively. IgA, IgM, and C3d (not shown) were also deposited
in the same fashion. (A, IgG; B, C4c; original magnification, 400·. )
DISCUSSION
Buerger reported a disease of young men, in
whom symptoms and signs of progressive vascular
insufficiency led inevitably to gangrene and amputa-
tion. Buerger termed the disease “thromboangiitis
obliterans” and distinguished it from atherosclerosis.1
He considered acute inflammation and occlusive
thrombosis of arteries and veins to be the characteris-
tic lesions of the clinicopathologic entity.10,11 In the
long period since Buerger reported thromboangiitis
obliterans, imprecise and conflicting clinical and
pathologic criteria have caused much confusion and
uncertainty in diagnosis. Tissue specimens seldom
included the acute phase lesion, which Buerger
viewed as essential for diagnosis.1,11,12
Chronic lesions, often said to be the least dis-
tinctive of the three stages of Buerger’s disease, may
be merely nonspecific residual evidence of arterial
occlusion.3,4,13 We examined all three stages by
means of immunohistochemistry to determine
which stage (acute, subacute, or chronic) possesses
distinctive features.
Regardless of pathologic stage, the elastic lamina
and all three layers of vessel walls were well pre-
served in Buerger’s disease, in contrast with athero-
sclerosis. Additionally, certain findings readily distin-
guish Buerger’s disease from other systemic vasculi-
tides. In giant cell arteritis, the internal elastic lamina
is characteristically disrupted and fragmented,14,15
and in polyarteritis nodosa (classified as a necrotiz-
ing vasculitis), fibrinoid necrosis occurs in the vessel
wall. Returning to comparisons with atherosclerosis,
no calcification or hyaline degeneration were found
in any cases of Buerger’s disease, and cell infiltrates
were more obvious in vessels affected by Buerger’s
disease.16,17
On the basis of our histologic observations, we
believe that Buerger’s disease is a vasculitis induced by
an antigen in the intimal layer. In the acute case, some
microabscesses were observed, indicating acute
inflammation in the intima, which likely induced
thrombus formation. Later, in the healing stage, vari-
ous immunological phenomena appeared in the
thrombus site. CD4+ T lymphocytes are inducers of
antibody production and regulators of cell-mediated
immune responses. CD8+ T lymphocytes display most
of the cytotoxic activity and the suppressor for pro-
duction of immunoglobulins. CD8+ T cells may be
involved in the initiation of the lesion, but CD4+ T
cells are at least as evident as CD8+ T cells during pro-
gression of the lesions. CD68+ macrophages and S-
100+ dendritic cells, thought to play a important role
in the immune reaction,18,19 were readily observed in
the intima. Both HLA-DR–expressing macrophages
and dendritic cells, as antigen-presenting cells in
immune and inflammatory processes, were demon-
strated mainly in the intima. In acute and subacute
stages, macrophages and dendritic cells in the intimal
layer appear to have been activated by an antigen.
Such HLA-DR positive macrophages and dendritic
cells may present an antigen from the intimal layer to
T lymphocytes in Buerger’s disease. In contrast, in
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Fig 6. Photograph of atherosclerotic control cases. Fibrointimal proliferation and hyaline degen-
eration were seen (I). Foam cells were seen in the proliferated intima. Internal elastic lamina
(arrowhead) and elastic fibers were found severely disrupted and fragmented. Cell infiltration were
observed in all three layers, however, it was scarce. (A, Original magnification, 100· ; hematoxylin-
eosin stain; B, original magnification, 100· ; elastica-van Gieson stain.) I, intima; M, media.
giant cell arteritis,20 disease-related CD4+ T cells and
dendritic cells are enriched in the adventitial layer, and
interferon(IFN)-g –secreting T cells accumulated in a
circular fashion in the inner adventitia along the exter-
nal elastic lamina. These findings also distinguish
Buerger’s disease from giant cell arteritis.
Both immunoglobulins and complement factors
are deposited in a linear manner along the elastic lam-
ina in Buerger’s disease, which is characteristic of the
acute or subacute phases. Although there are some
reports that atherosclerotic plaques contain immuno-
globulins deposits,21,22 linear deposits similar to those
in Buerger’s disease were never found in the athero-
sclerotic arteries that we studied. Furthermore, in
polyarteritis nodosa, deposits of immunoglobulins
and complements are not consistently found within
lesions, though circulating immune complexes are
common.23 These findings may imply that humoral
immunity, which is induced by B cell activation, also
plays an important role of immune reaction in the site
of Buerger’s disease. Usually, tissue damage caused by
immunoreaction, such as vasculitis or glomeru-
lonephritis, demonstrates deposition of not only
immunoglobulins, but also complements. Finally, sev-
eral unique, important observations in Buerger’s dis-
ease are the infiltration of HLA-DR+ cells and CD68+
cells, and deposition of immunoglobulins and com-
plement factors is linearly arranged along the inner
aspect of an undisrupted internal elastic lamina.
The identification of the inciting antigen in
Buerger’s disease remains unknown.3,4 Smoking,
infection, nutritional deficits, or general autoimmu-
nity may be responsible for the antigen in Buerger’s
disease.24,25 An as-yet-unidentified virus with or
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Table III. Results of immunohistochemical studies
Antibody
Case number CD68 CD3 CD8 CD4 CD20 CD56 CD57 HLA-DR S-100
Intima 1 3+ 3+ 2+ 2+ 1+ 1+ 1+ 3+ 2+
2 3+ 3+ 1+ 2+ 2+ 1+ 1+ 3+ 2+
3 3+ 3+ 2+ 1+ 1+ 1+ 1+ 3+ 2+
4 3+ 3+ 1+ 2+ 2+ 1+ 1+ 3+ 1+
5 3+ 3+ 1+ 1+ 2+ 1+ 1+ 1+ 1+
6 1+ 2+ 2+ 1+ 1+ 1+ 1+ – –
7 2+ 2+ 2+ 1+ 1+ – – 1+ –
8 2+ 2+ 2+ 1+ 1+ 1+ 1+ 2+ 1+
9 1+ 1+ 2+ 1+ 1+ – – 2+ 1+
Media 1 1+ – – – – – – 1+ 1+
2 – – 1+ 1+ – – – 1+ 1+
3 – 2+ – – – – – 1+ 1+
4 1+ 2+ 2+ 2+ 2+ 1+ 1+ 1+ 1+
5 1+ 1+ 1+ 1+ 1+ – – – –
6 – 1+ 1+ – 1+ – – – –
7 1+ 1+ – – – – – 1+ –
8 2+ 2+ 1+ 2+ 1+ – – 1+ 2+
9 1+ 1+ 1+ – – – – 2+ 1+
Adventitia 1 1+ 1+ – 1+ – – – 2+ 1+
2 2+ 1+ 1+ 1+ – – – 1+ 1+
3 2+ 2+ 1+ 1+ – – – 2+ 1+
4 1+ 1+ 1+ 1+ – – – 1+ –
5 1+ 1+ – 1+ – – – – 1+
6 – 2+ 1+ 1+ 1+ – – – –
7 1+ – – 1+ 1+ – – – –
8 2+ 1+ – 1+ – – – – –
9 1+ 1+ 1+ 1+ – – – 1+ –
Case No. 1, acute stage; 2 and 3, subacute stage; 4–9, chronic stage.
–, negative; 1+, 1%–10% positive of infiltrating cells; 2+, 11%–20% positive; 3+, more than 20% positive.
Table IV. Deposition of immunoglobulins and
complement factors along the elastic lamina
Case number IgG IgA IgM C3d C4c
1 + + + + +
2 + + + + +
3 + + + + +
4 + + + + +
5 + – + + +
6 + + + + +
7 – – – – –
8 + – + – –
9 – – + – –
Case No. 1, acute stage; 2 and 3, subacute stage; 4–9, chronic stage.
+, Readily detectable; –, not detectable.
without an intervening autoimmune process is
another potential stimulus.
In conclusion, from our observations, it seems
very likely that antigen presenting cells are activated
by some unidentified antigen in the blood, resulting
in an immunoreaction in Buerger’s disease. An
immune reaction (cellular, as well as humoral) is
restricted to the arterial intima, which defines
Buerger’s disease as an endarteritis.
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